| Original language | English |
|---|---|
| Pages (from-to) | 49-51 |
| Number of pages | 3 |
| Journal | Circulation Research |
| Volume | 132 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 6 2023 |
Bibliographical note
Funding Information:M.M. McDermott reports funding from the National Institute on Aging, National Heart Lung Blood Institute, American Heart Association, and Helixmith. She also reports other research support from ArtAssist, Mars, Helixmith, Chromadex, ReserveAge.
Funding Information:
M.M. McDermott reports funding from the National Institute on Aging, National Heart Lung Blood Institute, American Heart Association, and Helixmith. She also reports other research support from ArtAssist, Mars, Helixmith, Chromadex, ReserveAge.
Funding
M.M. McDermott reports funding from the National Institute on Aging, National Heart Lung Blood Institute, American Heart Association, and Helixmith. She also reports other research support from ArtAssist, Mars, Helixmith, Chromadex, ReserveAge. M.M. McDermott reports funding from the National Institute on Aging, National Heart Lung Blood Institute, American Heart Association, and Helixmith. She also reports other research support from ArtAssist, Mars, Helixmith, Chromadex, ReserveAge.
| Funders |
|---|
| ArtAssist |
| National Institute on Aging |
| National Heart, Lung, and Blood Institute (NHLBI) |
| American the American Heart Association |
Keywords
- Editorials
- cilostazol
- disability
- nitric oxide
- peripheral artery disease
- revascularization
- therapeutics
ASJC Scopus subject areas
- Physiology
- Cardiology and Cardiovascular Medicine
Fingerprint
Dive into the research topics of 'Praliciguat and Soluble Guanylate Cyclase Stimulators for Peripheral Artery Disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver